CSF1 and breast cancer: Moreover, immune checkpoint blockade could be combined with agents (e.g., CSF-1 inhibitors) that can inhibit TAMs accumulation and/or re-programme macrophages towards a more anti-tumoral M1-like phenotype in selected breast cancer patients.